Concomitant use of atomoxetine and OROS®-methylphenidate in a 10-year-old child suffering from attention-deficit/hperactivity disorder with comorbid bipolar disorder and Tourette syndrome

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 3, 2006, Pages 365-370

  Jaworowski, Sol ^a   Benarroch, Fortu ^a   Gross Tsur, Varda ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; CLONIDINE; HALOPERIDOL; METHYLPHENIDATE; OROS; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CHILD HOSPITALIZATION; COMORBIDITY; DISEASE COURSE; DISEASE EXACERBATION; DRUG BLOOD LEVEL; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; PHYSICAL EXAMINATION; POLYPHARMACY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SCHOOL CHILD; SIDE EFFECT; TIC; TREATMENT OUTCOME; WEIGHT GAIN;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLONIDINE; COMORBIDITY; DRUG THERAPY, COMBINATION; HUMANS; MALE; METHYLPHENIDATE; PROPYLAMINES; TICS; TOURETTE SYNDROME;

EID: 33745181646     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.365     Document Type: Article

References (42)

1. Bhatara VS, Feil M, Hoagwood K, Vitiello B, Zima B: Trends in combined pharmacotherapy with stimulants for children. Psychiatr Serv 53:244, 2002.
2. Biederman J, Newcorn J, Sprich S: Comorbidity of attention-deficit/ hyperactivity disorder with conduct, depressive anxiety and other disorders. Am J Psychiatry 48:564-577, 1991.
3. Biederman J, Spencer T: Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242, 1999.
4. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV: Therapeutic dilemmas in the pharmacotherapy of bipolar disorder in the young. J Child Adolesc Psychopharmacol 10:185-192, 2000.
5. Biederman J, Spencer T, Wilens T: Evidence-based pharmacotherapy for attention-deficit/hyperactivity disorder. Int J Neuropsychopharmacol 7:77-97, 2004.
6. Brown TE: Atomoxetine and stimulants in combination for treatment of attention-deficit/hyperactivity disorder: Four case reports. J Child Adolesc Psychopharmacology 14:129-136, 2004.
7. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threkheld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry K: Atomoxetine increases extracellular levels of norepinephrine and dopamine in the prefrontal cortex of rat: A potential mechanism for efficacy in attention-deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711, 2002.
8. Carlson GA, Newcorn J, Adler L, Barkley R, Greenhill L, Stein M: Stimulants and atomoxetine in the treatment of attention-deficit/hyperactivity disorder. J Clin Psychiatry, 19:2004.
9. Conners CK: Rating scales for use in drug studies of children. Psychopharmacol Bull 23:24-81, 1973.
10. Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223, 2002.
11. Denckla MB, Bemporad JR, Mackay MC: JAMA 29:1349-1351, 1976.
12. Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895-901, 2003.
13. Geller B, Zimmerman B, Williams M, Delbello MP, Bolhofer K, Frazier J: DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacol 12:11-26, 2002.
14. Greenhill LL, Vitiello B, Fisher P, Levine J, Davies M, Abikoff H, Chrisman AK, Chuang S, Findling RL, March J, Scahill L, Walkup J, Riddle MA: Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 43:1488-1496, 2004.
15. Henderson TA, Hartman K: Aggression, mania, and hypomania induction associated with atomoxetine. Pediatrics 114:895-896, 2004.
16. Henderson TA: Mania induction associated with atomoxetine. J Clin Psychopharmacol 5:567-568, 2004.
17. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM: Adjunctive antipsychotic treatment of adolescents. J Am Acad Child Adolesc Psychiatry 40:1448-1456, 2001.
18. Kowatch RA, Suppes T, Carmody TJ: Effect size of lithium, divalprex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713-720, 2000.
19. Kratochvil CJ, Heilingstein JH, Dittman R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: A prospective randomized, open label trial. J Am Acad Child Adolesc Psychiatry 41:776-784, 2002.
20. Kurlan R, for the Tourette Syndrome Group Study: Treatment of ADHD in children with tics: A randomized, controlled trial. Neurology 58:527-536, 2002.
21. Kutcher S: Practical clinical issues regarding child and adolescent psychopharmacology. Child Adolesc Psychiatr Clin N Am. 9:245-260, 2000.
22. Lanau F, Zenner M, Civelli O, Hartman DS: Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 68:804-812, 1997.
23. Law SF, Schachar RJ: J Am Acad Child Adolesc Psychiatry 38:944-995, 1999.
24. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ: The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Psychiatry 28:566-573, 1989.
25. McElroy SL, Altshuler LL, Suppes T, Keck PE, Jr, Denicoff KD, Nolen WA, Kripka RW, Leverich GS, Rochussen JR, Rush RM, Post RM: Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158:420-426, 2001.
26. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratchovil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West SA, Kelsey D, Wernicke J, Trapp NJ, Harder D: Once-daily atomoxetine treatment for children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study. Am J Psychiatry 159: 1896-190, 2002.
27. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, Atomoxetine ADHD Study Group: Atomoxetine in the treatment of children with ADHD: A randomized, placebo-controlled, dose-response study. Paediatrics 108:pe8, 2001.
28. The MTA Cooperative Group: A 14-month, randomized, clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56:1073-1086, 1999.
29. Safer DJ, Zito JM, dosReis S: Concomitant psychotropic medication for youth. Am J Psychiatry 160:438-444, 2003.
30. Sanchez L, Hagino O, Weller E, Weller R: Bipolarity in children. Psychiatr Clin North Am 22:629-648, 1999.
31. Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB: Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299, 2000.
32. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovitch L, Shepherd E, Amsten AF, Cohen DJ, Leckman JF: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention-deficit/hyperactivity disorder. Am J Psychiatry 158:1067-1074, 2001.
33. Scahill L, Leckman JF: Tic disorders, comprehensive Textbook of Psychiatry, Vol 2, Chap 42. Philadelphia, Lippincott Williams and Wilkins, 2004.
34. Solanto MV, Arnsten AFT, Castellanos FX: Stimulant drugs and ADHD: Basic and clinical neuroscience. New York, Oxford University Press, 2001.
35. Spencer T: The newest ADHD agent: Its place in the therapeutic armamentarium. Adv Stud Med 3:S458-S462, 2003.
36. Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearmam SK, Tarazi R, Faraone SV: A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit disorder. Arch Gen Psychiatry 59:649-656, 2002.
37. Steinberg S, Chouinard G: A case of mania associated with tomoxetine. Am J Psychiatry 142: 1517-1518, 1985.
38. Tamada RS, Issler CK, Amaral JA, Sachs GS, Lafer B: Treatment-emergent affective switch: A controlled study. Bipolar Disord 6:333-337, 2004.
39. Wagner KD: Polypharmacy for children. Psychiatr Times 78-79, 2000.
40. Woolston JL: Combined pharmacotherapy: Pitfalls of treatment. J Am Acad Child Adolesc Psychiatry 38:1455-1457, 1999.
41. Wozniak J: Recognizing and managing bipolar disorder in children. J Clin Psychiatry 66(Suppl 1): 18-23, 2005.
42. Young RC, Nysewander RW, Schreiber MT: Mania scale scores, signs and symptoms in forty inpatients. J Clin Psychiatry 44:98-100, 1983.